Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06114836

GERD Infant Feeding Therapeutics Trial (GIFT Trial)

Pathophysiological Evidence Driven Management of GERD in Neonatal ICU Infants: Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
369 (estimated)
Sponsor
Nationwide Children's Hospital · Academic / Other
Sex
All
Age
1 Day – 8 Months
Healthy volunteers
Not accepted

Summary

The goal of this investigator-initiated, single-center, randomized controlled trial (RCT) is to compare the effects of four weeks of three therapies on clinical and mechanistic outcomes based on pH-Imp testing using a three-arm parallel design in NICU infants with objective GERD diagnosis. The three therapies being compared are natural maturation, proton pump inhibitor (PPI) use, and added rice (AR) formula use. The main goals are: * to evaluate and compare the efficacy of the three commonly used treatment interventions used in the NICU for GERD in a randomized controlled manner with the primary endpoint of oral feeding success and absence of troublesome symptoms (as defined below). * to characterize the mechanisms of primary end point (success or failure) using pH-Impedance metrics.

Detailed description

In consented subjects, eligibility is determined after initial diagnostic 24-hour pH Impedance test. These subjects will be randomized to one of the 3 arms of the study (natural maturation, PPI, AR formula) for 4 weeks of treatment. A second 24-hour pH Impedance test will be done on therapy at 4 weeks or before discharge, whichever occurs first. Primary outcome will also be measured at 4 weeks or at discharge, whichever comes first.

Conditions

Interventions

TypeNameDescription
DRUGOmeprazoleOmeprazole will be the PPI prescribed for 4 weeks.
OTHERAR formulaAdded rice formula will be ordered for 4 weeks.

Timeline

Start date
2024-03-14
Primary completion
2027-11-01
Completion
2028-11-01
First posted
2023-11-02
Last updated
2024-10-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06114836. Inclusion in this directory is not an endorsement.